Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06310746
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-03-07
Brief Title:
A Randomized Double-Blind Placebo-Controlled Single-Dose Escalation Phase I Clinical Study to Assess the Safety Pharmacokinetics and Immunogenicity of HLX6018 in Healthy Subjects
Sponsor:
Organization:
Shanghai Henlius Biotech